GDP-L-Fucose Production Cost Reports

The report provides a detailed analysis essential for establishing a GDP-L-fucose production plant. It encompasses all critical aspects necessary for GDP-L-fucose production, including the cost of GDP-L-fucose production, GDP-L-fucose plant cost, GDP-L-fucose production costs, and the overall GDP-L-fucose production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a GDP-L-fucose production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

GDP-L-fucose is a nucleotide sugar donor in industrial glycosylation processes. It enables the enzymatic synthesis of fucosylated glycans such as sialyl Lewis X and human milk oligosaccharides like 2'-fucosyllactose (2'-FL), which are incorporated into infant formulas for their prebiotic benefits in gut health and immunity. In bioproduction, cell-free multi-enzyme cascades convert mannose to GDP-L-fucose, while microbial platforms like engineered Bacillus subtilis achieve 1.6 g/L L-fucose via GDP-L-fucose hydrolysis. It supports scalable production of food-grade nutraceuticals and pharmaceutical glycoconjugates. These biotech routes replace expensive algal extractions, facilitating applications in glycoengineering research, anti-inflammatory therapeutics targeting leukocyte adhesion, and high-value materials for regenerative medicine.

GDP-L-fucose’s market growth is propelled by surging demand for fucosylated human milk oligosaccharides (HMOs) like 2'-fucosyllactose in infant nutrition, where it acts as a biosynthetic precursor. The global regulatory approvals for prebiotic fortification, along with rising biopharma needs for glycoengineered therapeutics targeting inflammation and cancer via sialyl Lewis X structures boosts the market growth. Advancements in cost-effective microbial fermentation and cell-free enzyme cascades reduce reliance on algal sources, enabling scalable supply for nutraceuticals, cosmetics, and functional foods, driven by Asia-Pacific industrialisation and North American biopharma innovation. Heightened health consciousness, sustainability mandates for natural ingredients, and expanding applications in regenerative medicine further accelerate adoption. However, high substrate expenses for GTP and nucleotides impact industrial GDP-L-fucose procurement, where ATP regeneration and ADP inhibition management are important, making scalable, cost-effective biotech routes essential over algal extraction.

Raw Material for GDP-L-Fucose Production

According to the GDP-L-fucose production plant project report, the various raw materials for GDP-L-fucose production include D-mannose and glucokinase.

Production Process of GDP-L-Fucose

The extensive GDP-L-fucose production cost report consists of the following major industrial production process:

1. Production via the de novo pathway: The production process of GDP-L-fucose occurs via the de novo pathway. The de novo process starts with D-mannose phosphorylation by glucokinase (Glk) to form mannose-6-phosphate, followed by isomerisation via phosphomannomutase (ManB) to give mannose-1-phosphate. The next step involves guanylylation by mannose-1-phosphate guanylyltransferase (ManC) to form GDP-D-mannose, followed by dehydration by GDP-mannose 4,6-dehydratase (Gmd) to obtain GDP-4-keto-6-deoxymannose. The final step involves epimerisation/reduction by WcaG to GDP-L-fucose, implemented in cell-free multi-enzyme cascades.

Properties of GDP-L-Fucose

GDP-L-fucose is a nucleotide-activated sugar with the molecular formula C16H25N5O15P2 and a molecular weight of 589.3 g/mol (free acid) or 633.3 g/mol for the disodium salt form. It appears as a solid, highly soluble in water up to 250 mg/mL (424.20 mM, requiring ultrasonication). It has a topological polar surface area of 307 Ų with 38 heavy atoms, reflecting its hydrophilic nature suited for enzymatic glycosylation. It is chemically stable when stored at 4 degree Celsius, protected from light. It serves as the L-fucosyl donor in fucosyltransferase reactions, with collision cross-sections of 217.2 Ų [M+H]⁺ and 206.72 Ų [M-H]^- under ESI-MS conditions.